USE OF BLOOD, BLOOD PRODUCTS AND MONITORING SYSTEM(HEMOIGILANCE) IN THE CONTEXT OF HEALTH LAW EXAMINATION OF THE RESPONSIBILITY OF THE ADMINISTRATION IN TERMS OF PUBLIC LAW

Abstract

Blood is a specific fluid that is necessary for the protection and maintenance of health, consisting of living tissues and cells. In modern medicine, the patient is transfused with whole blood or components as needed. Blood transfusion is a medical treatment. The primary aim of all medical treatments is to provide benefit and achieve effective results. In order to ensure that the decided blood type does not harm the patient, tests are performed to identify diseases that can be transmitted through blood, and to prevent possible reactions and to prevent other harms, donor and patient blood are cross-compared. As a primary precaution in order to obtain the expected benefit from the treatment, all harmful elements that would put the patient's life at risk are eliminated. Before blood transfusion, the patient is informed about the benefits and harms of the blood or its component to be used and written consent is obtained. The patient is warned to report any reactions that may occur during any stage of transfusion to the nurse or physician. In this article; The sanctions to be applied to those responsible and the legal liability of the administration in order to eliminate the damages that cause the violation of the right to health and life of the service recipients due to the service not functioning well and as required during the process of taking blood and blood products, storing them, delivering them to those in need and transfusion are examined in terms of health law.